Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. / Flint, A.; Raben, Anne; Astrup, Arne; Holst, Jens Juul.

    In: Journal of Clinical Investigation, Vol. 101, No. 3, 1998, p. 515-520.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Glucagon-like peptide-1 - a new hormone and a new drug. / Holst, J.J.

    In: Ugeskrift for læger, No. 160, 1998, p. 2371-2377.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Am. J. Physiol., No. 275, 1998, p. G984-G992.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 2284-2290.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. / Wojdemann, M.; Wettergren, A.; Hartmann, Bolette; Holst, J.J.

    In: Scandinavian Journal of Gastroenterology, No. 33, 1998, p. 828-832.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. / Naslund, E.; Backman, L.; Holst, J.J.; Theodorsson, E.; Hellstrom, P.M.

    In: Obes. Surg., No. 8, 1998, p. 253-260.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. / Nauck, M.A.; Sauerwald, A.; Ritzel, R.; Holst, J.J.; Schmiegel, W.

    In: Diabetes Care, No. 21, 1998, p. 1925-1931.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Inhibition of human gastric lipase secretion by glucagon-like peptide-1. / Wojdemann, M.; Wettergren, A.; Sternby, B.; Holst, J.J.; Larsen, S.; Rehfeld, J.F.; Olsen, O.

    In: Dig. Dis. Sci., No. 43, 1998, p. 799-805.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. / Holst, J.J.; Deacon, C.F.

    In: Diabetes, No. 47, 1998, p. 1663-1670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: J. Clin. Invest., No. 102, 1998, p. 764-774.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207